The tunneled catheter for haemodialysis: about 52 cases

##plugins.themes.academic_pro.article.main##

Badreddine Ben Kaab
Rania Kheder
Héla Jbali
Wided Smaoui
Madiha Krid
Lamia Raies
Lilia Ben Fatma
Souméya Béji
Med Karim Zouaghi
Fatma Ben Moussa

Abstract

SUMMARY
Background: Vascular access is a basic and essential tool required for performing renal replacement therapy in end stage renal disease.
Aim: To study the indications of tunneled catheter (KTT) in hemodialysis (HD), identify complications related to the use of KTT and contributing factors, assess the survival and performance of the technique.
Introduction: The making of a vascular access is an angular piece for adequate HD and in good conditions. In this context the KTT may be an alternative.
Methods: A retrospective study of 52 KTT placed in 49 patients collected in the department of Nephrology Dialysis and Renal Transplantation in RABTA Tunis between 2008 and 2011.
Results: The average age of our patients was 55.58 years ± 13.5 years, their Sex ratio was 0.79. The Thirty of our patients were diabetic, 46.2% had hypertension and 21.2% had underlying cardiac disease. The mean duration of HD was 1111.35 days or 37 months. The most common indication of KTT was the absence of arteriovenous fistula in 65.4% of cases, other indications were: short survival (30.7%), the exhaustion of venous capital (34.6%), mediacalcosis (34.6%) and immunosuppression (36.5%). The right internal jugular vein was the choice of insertion site with 78.8%. The overall incidence of immediate complications was 19.2%. Among our patients, 31.4% had a dysfunction. The period of HD represent the risk factor for dysfunction KTT (p = 0.006).An infectious complication was observed in 29% of cases. The median time to onset of infection was 190.83 days. Staphylococcus was isolated in 40% of cases. The average duration of use of KTT was 238 days. The only single factor determining the survival of KTT was the number of KTT put in the same patient.
Conclusion:More than a quarter of the population are dialyzed through a catheter. Despite concerted efforts, much remains to be done for the confection at time of a permanent vascular access.

Keywords:

Central venous catheters, hemodialysis, dysfunction, infection, survival.

##plugins.themes.academic_pro.article.details##

References

  1. Canaud B, Leray MH, Garrigues V, Mion C. Permanent twin catheter: a vascular access option for haemodialysis in elderly patients. Nephrol Dial Transplant1998;13:82-8.
  2. Shaffer D, Madras PN, Williams ME, D'Elia JA, Kaldany A, Monaco AP. Use of Dacrocuffed silicone catheters as long-term hemodialysis access. ASAIO journal 1992;38:55-8.
  3. Vats HS, Bellingham J, Pinchot JW, Young HN, Chan MR, Yevzlin AS. A comparison between blood flow outcomes of tunneled external jugular and internal jugular hemodialysis catheters. J Vasc Access 2012;13:51-4.
  4. Canaud B, Chenine L, Formet C, Leray-Moragues H. Accès veineux pour hémodialyse: Technique, indication, résultats et développement futur. Actualités néphrologiques 2005;251-71.
  5. Bagul A, Brook NR, Kaushik M, Nicholson ML. Tunnelled catheters for haemodialysis patient. Eur J VascEndovascSurg 2007;33:105-12.
  6. Edwin RC, Bonilla M, Perez J. Percutaneous translumbar inferior vena cava catheter placement for long-term hemodialysis treatment. Pediatric Nephrol 2007;22:612-5.
  7. Punzi M, Ferro F, Petrosino F et al. Use of intra-aortic Tesio catheter as vascular access for haemodialysis. Nephrol Dial Transplant 2003;18:830-2.
  8. Betz C, Kraus D, Müller C, Geiger H. Iliac cuffed tunneled catheters for chronic haemodialysis vascular access. Nephrol Dial Transplant 2006;21:2009-12.
  9. Sampathkumar K, Ramakrishnan M, Sah AK, Sooraj Y, Mahaldhar A, Ajeshkumar R. Tunneled central venous catheters: Experience from a single center. Indian Journal of Nephrology 2011;21:107-11.
  10. Wivell W, Bettmann MA, Baxter B, Langdon DR, Remilliard B, Chobanian M. Outcomes and performance of the Tesio Twin catheter system placed for hemodialysis access. Radiology 2001;221:697-703
  11. Suhocki PV, Conlon PJ, Knelson MH, Harland R, Schwab SJ. Silastic cuffed for hemodialysis vascular access: Thrombolytic and mechanical correction of malfunction. Am J Kidney Dis 1996;28:379-86.
  12. Fry AC, Stratton J, Farrington K et al. Factors affecting long-term survival of tunneled haemodialysis catheters a prospective audit of 812 tunnelled catheters. Nephrol Dial Transplant 2008;23:275-81.
  13. Trerotola SO, Johnson MS, Harris VJ et al. Outcomes of tunneled hemodialysis catheters placed via the right internal jugular vein by interventional radiologists. Radiology 1997;203:489-95.
  14. Lund GB, Trerotola SO, Scheel PF et al. Outcomes of tunneled hemodialysis catheters placed by radiologists. Radiology 1996;198:467- 72.
  15. Canaud B, Leray-Moragues H, Kerkeni N, Bosc JY, Martin K. Effective flow performances and dialysis doses delivered with permanent catheters: a 24 months comparative study of permanent catheters versus arterio-venous vascular access. Nephrol Dial Transplant 2002;17:1286-92.
  16. NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation-Dialysis Outcomes Quality Initiative 2006.
  17. Funaki B. Tunneled central venouscatheter insertion. Seminars in interventionalradiology 2008;25:432-6.
  18. Klouche K, Delabre JP, Amigues L, Jonquet O, Canaud B. Place des cathéters tunnélisés dans la prise en charge de l'insuffisance rénale aigue par épuration extrarénale. Réanimation 2009;18:714-9.
  19. Konner K. History of vascular access for haemodialysis. Nephrol Dial Transplant 2005;20:2629-35.
  20. Ramsey C, McClure H, Bhambra B, Dolling S, Bodenham A. Early cuff anchorage for tunneled central venous catheters using a buried absorbable suture. J Vasc Access 2012;13:96-100.
  21. Liangos O, Gul A, Madias NE, Jaber BL. Long term management of the tunneled venous catheter. Seminars in Dialysis 2006;19:158-64.
  22. Port FK, Pisoni RL, Bommer J et al. Improving outcomes for dialysis patients in the international dialysis outcomes and practice patterns study. Clin J Am SocNephrol 2006;1:246-55.
  23. Allon M, Depner TA, Radeva M, Bailey J. Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO study. J Am SocNephrol 2003;14:1863-70.
  24. Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 2005; 68:311-8
  25. Carrière C, Marchandin H. Infection liées aux cathéters veineux centraux: diagnostic et définitions. Néphrologie 2001;22:433-7.
  26. Lok E. Avoiding trouble down the line: The management and prevention of hemodialysis catheter-related infection. Advances in Chronic Kidney Disease 2006;13:225-44.
  27. Beathard GA, Urbanes A. Infection associated with tunneled hemodialysis catheters. Seminars in Dialyis 2008;21:528-538.
  28. Lok E, Mokrzycki MH. Prevention and management of catheter-related infection in hemodialysis patients. Kidney International 2011;79:587-598.
  29. O'Grady NP, Alexander M, Burns LA et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011;39:S1-34.
  30. Pengloan J. Is there a time limit for central venous catheter use for hemodialysis? Néphrologie 2001;22:411-2.
  31. Little MA, O'Riordan A, Lucey B et al. A prospective study of complications associated with cuffed tunnelledhaemodialysis catheters. Nephrol Dial Transplant 2001;16:2194-200.
  32. Al-Hwiesh AK, Abdu-Rahman IS. Tunneled femoral vein catheterization for long term hemodialysis: A single center experience. Saudi J Kidney Dis Transplant 2007;18:37-42.
  33. Cetinkaya R, Odabas AR, Unlu Y, Selcuk Y, Ates A, Ceviz M. Using cuffed and tunnelled central venous catheters as permanent vascular access for haemodialysis: a prospective study. Ren Fail 2003;25:431-8.